SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009030
Filing Date
2022-05-10
Accepted
2022-05-10 16:40:09
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cinc-20220331.htm   iXBRL 10-Q 1658641
2 EX-31.1 cinc-ex31_1.htm EX-31.1 18979
3 EX-31.2 cinc-ex31_2.htm EX-31.2 19026
4 EX-32.1 cinc-ex32_1.htm EX-32.1 21581
  Complete submission text file 0000950170-22-009030.txt   6087944

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cinc-20220331.xsd EX-101.SCH 44830
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cinc-20220331_def.xml EX-101.DEF 183731
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cinc-20220331_pre.xml EX-101.PRE 295382
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cinc-20220331_cal.xml EX-101.CAL 31546
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cinc-20220331_lab.xml EX-101.LAB 403062
50 EXTRACTED XBRL INSTANCE DOCUMENT cinc-20220331_htm.xml XML 948909
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41201 | Film No.: 22910491
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences